Inflammation and oxidative stress, rather than hypoxia, are predominant factors promoting angiogenesis in the initial phases of atherosclerosis

Xiao,Weigang; Jia,Zhenhua; Zhang,Qiuyan; Wei,Cong; Wang,Hongtao; Wu,Yiling

doi:10.3892/mmr.2015.3800

Inflammation and oxidative stress, rather than hypoxia, are predominant factors promoting angiogenesis in the initial phases of atherosclerosis

Authors:
- Weigang Xiao
- Zhenhua Jia
- Qiuyan Zhang
- Cong Wei
- Hongtao Wang
- Yiling Wu
View Affiliations

Affiliations: Graduate School Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China, Cardiovascular Medicine, Affiliated Yiling Hospital of Hebei Medical University, Shijiazhuang, Hebei 050091, P.R. China, Pharmacology Lab, Yiling Pharmaceutical Research Institute, Shijiazhuang, Hebei 050035, P.R. China, Key Laboratory of State Administration of Traditional Chinese Medicine, Shijiazhuang, Hebei 050035, P.R. China
Published online on: May 19, 2015 https://doi.org/10.3892/mmr.2015.3800
Pages: 3315-3322
Copyright: © Xiao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Micro-angiogenesis in the arterial wall has been observed during the development and progression of atherosclerosis. The aim of the present study was to examine whether inflammation, oxidative stress and hypoxia are involved in the process of early atherosclerotic micro‑angiogenesis. A total of 24 rabbits were randomly divided into a normal diet group or a high‑cholesterol (HC) diet group and were fed the corresponding diets for 4 weeks. The microvessel density (MVD), level of hypoxia and the levels of inflammatory markers and antioxidants in the arterial wall were detected using immunohistochemical and molecular biological techniques, respectively. The present results demonstrated that the MVD in the HC group was significantly higher (P<0.01) than that observed in the rabbits, which were provided with a normal diet, while hypoxia‑inducible factor‑1α levels did not exhibit marked changes in either of the two groups (P>0.05). The levels of inflammatory markers and antioxidants were significantly different between the two groups (P<0.05). The present study demonstrated that the primary factors, which promote micro‑angiogenesis are possibly associated with an increase in inflammation and a decrease in the levels of antioxidants, as tissue hypoxia in the arterial wall at this stage was not evident.

View Figures

View References

1	Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
2	Gustafson B: Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb. 17:332–341. 2010. View Article : Google Scholar : PubMed/NCBI
3	Madamanchi NR, Vendrov A and Runge MS: Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 25:29–38. 2005.
4	Moreno PR, Purushothaman KR, Sirol M, Levy AP and Fuster V: Neovascularization in human atherosclerosis. Circulation. 113:2245–2252. 2006. View Article : Google Scholar : PubMed/NCBI
5	Silva ES, Giglio PN, Waisberg DR, Filho RG, Casella IB and Puech-Leäo P: Obesity is a risk factor for significant carotid atherosclerosis in patients aged 39 to 55 years. Angiology. 65:602–606. 2013. View Article : Google Scholar : PubMed/NCBI
6	Hildebrandt HA, Gossl M, Mannheim D, et al: Differential distribution of vasa vasorum in different vascular beds in humans. Atherosclerosis. 199:47–54. 2008. View Article : Google Scholar
7	Galili O, Herrmann J, Woodrum J, Sattler KJ, Lerman LO and Lerman A: Adventitial vasa vasorum heterogeneity among different vascular beds. J Vasc Surg. 40:529–535. 2004. View Article : Google Scholar : PubMed/NCBI
8	Langheinrich AC, Michniewicz A, Bohle RM and Ritman EL: Vasa vasorum neovascularization and lesion distribution among different vascular beds in ApoE^−/−/LDL^−/− double knockout mice. Atherosclerosis. 191:73–81. 2007. View Article : Google Scholar
9	Kumamoto M, Nakashima Y and Sueishi K: Intimal neovas-cularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol. 26:450–456. 1995. View Article : Google Scholar : PubMed/NCBI
10	Moulton KS, Vakili K, Zurakowski D, et al: Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA. 100:4736–4741. 2003. View Article : Google Scholar : PubMed/NCBI
11	Herrmann J, Lerman LO, Rodriguez-Porcel M, et al: Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res. 51:762–766. 2001. View Article : Google Scholar : PubMed/NCBI
12	Sluimer JC and Daemen MJ: Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol. 218:7–29. 2009. View Article : Google Scholar : PubMed/NCBI
13	Jeziorska M and Woolley DE: Neovascularization in early atherosclerotic lesions of human carotid arteries: its potential contribution to plaque development. Hum Pathol. 30:919–925. 1999. View Article : Google Scholar : PubMed/NCBI
14	Santilli SM, Kronson J and Payne WD: The effect of hypercholesterolemia on the rabbit transarterial wall oxygen gradient. Ann Vasc Surg. 12:418–423. 1998. View Article : Google Scholar : PubMed/NCBI
15	Tonar Z, Kural T Jr, Kochová P, Nedorost L and Witter K: Vasa vasorum quantification in human varicose great and small saphenous veins. Ann Anat. 194:473–481. 2012. View Article : Google Scholar : PubMed/NCBI
16	Khurana R, Zhuang Z, Bhardwaj S, et al: Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation. 110:2436–2443. 2004. View Article : Google Scholar : PubMed/NCBI
17	Barger AC, Beeuwkes R III, Lainey LL and Silverman KJ: Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med. 310:175–177. 1984. View Article : Google Scholar : PubMed/NCBI
18	Wilson SH, Herrmann J, Lerman LO, et al: Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation. 105:415–418. 2002. View Article : Google Scholar : PubMed/NCBI
19	Wilson SH, Caplice NM, Simari RD, Holmes DR Jr, Carlson PJ and Lerman A: Activated nuclear factor-κB is present in the coronary vasculature in experimental hypercholesterolemia. Atherosclerosis. 148:23–30. 2000. View Article : Google Scholar
20	Wu N, Zhang X and Jia D: Highdose fasudil preconditioning and postconditioning attenuate myocardial ischemia reperfusion injury in hypercholesterolemic rats. Mol Med Rep. 9:560–566. 2014.
21	Johnston DA, Dong B and Hughes CC: TNF induction of jagged-1 in endothelial cells is NFκB-dependent. Gene. 435:36–44. 2009. View Article : Google Scholar : PubMed/NCBI
22	Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V and Nuseir N: Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α. Nature. 329:630–632. 1987. View Article : Google Scholar : PubMed/NCBI
23	Salani D, Taraboletti G, Rosano L, et al: Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol. 157:1703–1711. 2000. View Article : Google Scholar : PubMed/NCBI
24	Herrmann J, Best PJ, Ritman EL, Holmes DR Jr, Lerman LO and Lerman A: Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Am Coll Cardiol. 39:1555–1561. 2002. View Article : Google Scholar : PubMed/NCBI
25	Quehenberger P, Bierhaus A, Fasching P, et al: Endothelin 1 transcription is controlled by nuclear factor-κB in AGE-stimulated cultured endothelial cells. Diabetes. 49:1561–1570. 2000. View Article : Google Scholar : PubMed/NCBI
26	Duracková Z: Some current insights into oxidative stress. Physiol Res. 59:459–469. 2010.
27	Kondo T, Hirose M and Kageyama K: Roles of oxidative stress and redox regulation in atherosclerosis. J Atheroscler Thromb. 16:532–538. 2009. View Article : Google Scholar : PubMed/NCBI
28	Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN and Rutledge JC: Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci. 63:1–9. 2011. View Article : Google Scholar : PubMed/NCBI
29	Ma Q: Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 53:401–426. 2013. View Article : Google Scholar : PubMed/NCBI
30	Lee JM and Johnson JA: An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol. 37:139–143. 2004. View Article : Google Scholar : PubMed/NCBI
31	Zakkar M, Van der Heiden K, Luong A, et al: Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler Thromb Vasc Biol. 29:1851–1857. 2009. View Article : Google Scholar : PubMed/NCBI
32	Aoki M, Nata T, Morishita R, et al: Endothelial apoptosis induced by oxidative stress through activation of NF-κB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension. 38:48–55. 2001. View Article : Google Scholar : PubMed/NCBI
33	West XZ, Malinin NL, Merkulova AA, et al: Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature. 467:972–976. 2010. View Article : Google Scholar : PubMed/NCBI
34	Okuno Y, Nakamura-Ishizu A, Otsu K, Suda T and Kubota Y: Pathological neoangiogenesis depends on oxidative stress regulation by ATM. Nat Med. 18:1208–1216. 2012. View Article : Google Scholar : PubMed/NCBI